EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Hyperhemolysis in a sickle cell disease patient in pregnancy

Kristen Warncke, Alecia Nero, Ravindra Sarode, Brian D Adkins, Jamie Morgan, Natalie Bavli

Annals of Hematology · 2025

DOI: 10.1007/s00277-025-06264-7 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Annals of Hematology, 2025. Verfasst von Kristen Warncke und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics & Gynecology, University of Texas Southwestern Medical Center, Dallas, TX, USA. kristen.warncke@utsouthwestern.edu. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Hemolysis, Pregnancy Complications, Hematologic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sickle cell disease (SCD) is the most commonly inherited hemoglobinopathy with the potential for significant maternal and perinatal morbidity and mortality. Hyperhemolysis syndrome (HS) is a rare, and potentially fatal complication of blood transfusion characterized by destruction of both transfused and autologous red blood cells, often resulting in severe anemia with post-transfusion hemoglobin levels lower than pre-transfusion levels. Evidence-based guidance on the prevention and management of HS during pregnancy is limited. We report the case of a 23-year-old gravida 1 para 0 with sickle cell anemia and a history of two prior episodes of HS, successfully managed through a multidisciplinary approach. Her care team included hematologists, maternal-fetal medicine specialists, transfusion medicine pathologists, and neonatologists. Management during pregnancy involved initiating hydroxyurea in the second trimester, implementing a transfusion-restricted protocol, and utilizing immunosuppression and blood conservation strategies. This case highlights the successful application of a multidisciplinary approach to the management of a high-risk pregnancy complicated by SCD and recurrent HS. Key interventions included the use of hydroxyurea, erythropoiesis-stimulating agents, immunosuppression, and a planned delivery strategy, resulting in a favorable maternal and neonatal outcome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Sickle CellHemolysisPregnancy Complications, HematologicFemaleHumansPregnancyYoung AdultHydroxyurea

Stichwörter der Autor:innen

Hyperhemolysis syndromePregnancySickle cell diseaseTransfusion

Substanzen

Hydroxyurea

Autor:innen und Institutionen

  • Department of Obstetrics & Gynecology, University of Texas Southwestern Medical Center, Dallas, TX, USA. kristen.warncke@utsouthwestern.edu.
  • Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX, 75390-9032, USA. kristen.warncke@utsouthwestern.edu.
  • Department of Hematology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Department of Obstetrics & Gynecology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Zitieren

APA

Warncke, K., Nero, A., Sarode, R., Adkins, B. D., Morgan, J., & Bavli, N. (2025). Hyperhemolysis in a sickle cell disease patient in pregnancy. Annals of Hematology. https://doi.org/10.1007/s00277-025-06264-7

Vancouver

Warncke K, Nero A, Sarode R, Adkins BD, Morgan J, Bavli N. Hyperhemolysis in a sickle cell disease patient in pregnancy. Annals of Hematology. 2025. doi:10.1007/s00277-025-06264-7

BibTeX
@article{Warncke2025,
  author = {Warncke, Kristen and Nero, Alecia and Sarode, Ravindra and Adkins, Brian D and Morgan, Jamie and Bavli, Natalie},
  title = {Hyperhemolysis in a sickle cell disease patient in pregnancy},
  journal = {Annals of Hematology},
  year = {2025},
  doi = {10.1007/s00277-025-06264-7}
}
Kostenlos starten →